Nicholas Boston
@Highvista Strategies Llc
Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.
Assets under management
The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
XPOXpo Inc
| 1.4% | $4.051M 37,680 shares@ $107.52 avg price | Increased 47.89% |
PTGXProtagonist Therapeutics Inc
| 1.39% | $4.028M 89,508 shares@ $45.0 avg price | Increased 321.64% |
HESHess Corp
| 1.36% | $3.925M 28,900 shares@ $135.8 avg price | |
ARGXArgenx Se
| 1.34% | $3.878M 7,154 shares@ $542.08 avg price | Increased 8.33% |
AMEDAmedisys Inc
| 1.31% | $3.788M 39,250 shares@ $96.52 avg price | |
GEVGe Vernova Inc
| 1.3% | $3.748M 14,700 shares@ $254.98 avg price | New Position |
AXSMAxsome Therapeutics Inc
| 1.29% | $3.733M 41,542 shares@ $89.88 avg price | Decreased -33.2% |
MRUSMerus N V
| 1.28% | $3.696M 73,980 shares@ $49.97 avg price | Decreased -36.61% |
APGEApogee Therapeutics Inc
| 1.26% | $3.629M 61,788 shares@ $58.74 avg price | Decreased -21.72% |
ACIAlbertsons Cos Inc
| 1.21% | $3.488M 188,753 shares@ $18.48 avg price |